SpotCheck: A skin cancer diagnostic accuracy study comparing teledermoscopy with and without electrical impedance spectroscopy to in-person dermatologist evaluation of patient-identified lesions concerning them for skin cancer - 07/12/24
Doi : 10.1016/j.jaad.2024.10.067
Jenne P. Ingrassia, BA a, b, Shirin Bajaj, MD a, Avani Kolla, MD a, Vivienne Li, BA a, Payal Shah, MD a, Nicholas Gulati, MD, PhD a, Maressa C. Criscito, MD a, Yiping Xing, MD a, Adriana Lopez, MD a, Duy C. Tran, MD a, Vignesh Ramachandran, MD a, Efe Kakpovbia, MS, MD a, Shane Meehan, MD a, Yongzhao Shao, PhD c, d, Kristen Lo Sicco, MD a, Emily C. Milam, MD a, Amy K. Bieber, MD a, Amanda Levine, MD a, Tracey N. Liebman, MD a, Jennifer A. Stein, MD, PhD a, David Polsky, MD, PhD a, d, ⁎ 
a Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, NYU Langone Health, New York, New York
b New York Medical College, Valhalla, New York
c Department of Population Health, New York University Grossman School of Medicine, NYU Langone Health, New York, New York
d Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York
∗Correspondence to: David Polsky, MD, PhD, Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, 522 First Avenue, SML-404, New York, NY 10016522 First Avenue, SML-404New YorkNY10016
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 07 December 2024
Key words : basal cell carcinoma, melanoma, nonmelanoma skin cancers, skin cancer, squamous cell carcinoma, teledermoscopy, telemedicine
Plan
| Funding sources: This work was supported by the Melanoma Research Alliance, Sergei S. Zlinkoff Foundation for Medical Education, Orbuch Brand Pilot Program for Diseases of the Skin, and Ronald O. Perelman Department of Dermatology. In-kind support from SciBase. |
|
| Patient consent: All patients consented to their participation, including the use of photographs, for the study. No identifiable material is included in this manuscript. |
|
| IRB approval status: Reviewed and approved by NYU IRB# i19-01242 on March 12, 2020. |
|
| Data sharing: Individual participant data that underlie the published results will be available for sharing after deidentification beginning 9 months and ending 36 months following article publication. Data will be made available upon reasonable request to investigators who propose to use the data. Requests should be directed to David.Polsky@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. |
© 2024
Publié par Elsevier Masson SAS.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?